Esophageal squamous cell carcinoma
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: (1) Newly diagnosed early squamous cell carcinoma of the esophagus. (2) Complete endoscopic resection as assessed visually on Lugol chromoendoscopy immediately after EMR. (3) A diagnosis of squamous cell carcinoma on histopathological examination of the resected specimen. (4) Vertical margins of the resected specimen are confirmed to be tumor-negative. (5) Tumor invasion is limited to the mucosa on histopathological examination of the resected specimen, and no additional treatment (surgical resection, radiotherapy, chemotherapy, etc.) is performed immediately after EMR. (6) No active head or neck cancers. (7) The investigator judges that patient can be observed for at least 2 years. (8) Written informed consent is obtained from the patient.
Exclusion criteria
Exclusion criteria: (1) A history of chemotherapy for any other cancers or a history of surgical treatment or radiotherapy for head and neck cancers. (2) A history of iodine allergy. (3) Patients whom the investigator considers unsuitable as subjects for this study.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The cumulative incidence of metachronous multiple cancers of the esophagus as assessed by the Lugol-voiding pattern. | — |
Secondary
| Measure | Time frame |
|---|---|
| 1) The total annual number of cases of metachronous multiple cancer of the esophagus as assessed by the Lugol-voiding pattern. 2) The cumulative incidence of metachronous multiple cancers of the head and neck region as assessed by the Lugol-voiding pattern. | — |
Countries
Japan
Contacts
Kitasato University Hospital Department of Gastroenterology